When you take a medicine, how often do you wonder whether it still works? You might check the expiry date. You probably don’t think about how hot it got on its journey to the pharmacy. Yet a medicine can lose some of its strength in the heat and still look exactly the same.As a physicist, I learned early that heat can speed up the chemical reactions that break things down. For some reactions, an extra 10°C can roughly double the rate. That matters when a box of medicines spends hours in the back of a truck or days in a warehouse. As the world warms, we need to know how much heat medicines can withstand before they start to lose their strength.As negotiators work in Antalya during Cop31, they will pore over projections of how much hotter the world is getting as we continue to emit billions of tons of carbon dioxide each year. They are right to ask what each fraction of a degree could mean. But one question has received too little attention: what happens to our medicines as the world gets hotter?Pregnancy is where these forces meet most cruelly. A major review in The BMJ medical journal found that the odds of a premature birth rise by about 5 per cent for every 1°C increase in temperature, and by 16 per cent during a heatwave. The risk falls hardest on the poorest women, in the hottest places.Heat also attacks the medicines meant to protect them. Severe bleeding after childbirth kills around 70,000 women a year. Oxytocin, a medicine used to prevent that bleeding, needs to be kept refrigerated from the factory to the maternity ward. If the power goes out and the fridge warms up, the medicine can lose strength. A midwife reaching for a vial can’t tell by looking whether it’s still potent. The consequences may only become apparent in the labour ward, when there is no time to find another.Better options exist. Heat-stable carbetocin, which a large The World Health Organisation (WHO) trial found to be as safe and effective as oxytocin for prevention, can keep its strength for three years at temperatures up to 30°C without a fridge. At the global health partnership Unitaid, we’re helping get it to the women who need it.But we’re also looking at the other side of the problem. At least with oxytocin, the label is clear: keep it between 2°C and 8°C. Most medicines are approved for storage at “room temperature” – but assume they will be stored at no more than 30°C. What happens when those limits are exceeded – in shipping containers, warehouses or health facilities without reliable cooling? And how well do we understand the cumulative effects of repeated exposure to heat and humidity? As temperatures rise, these questions become increasingly urgent.This year during Cop31, Unitaid has launched the Safeguarding Heat Stability in Essential Life-Saving Drugs and Diagnostics project – known as SHIELD – an £8 million initiative, supported by donors including the UK, who founded and continue to support Unitaid. SHIELD asks what a warming world does to our medicines. We will measure the heat and humidity medicines actually face from port to patient, to identify which are at risk, and figure out ways to protect them: sometimes with a better molecule, sometimes a better box, sometimes a better supply chain. What it learns will be free for every country to use.Britain helped put health at the centre of climate negotiations at Cop26 in Glasgow. It has also helped drive efforts to reduce emissions from health care through the Sustainable Markets Initiative, founded by King Charles, while the NHS was the first health system to commit to net zero. These are important steps, but the climate challenge does not stop at Britain’s borders. The UK has an opportunity to extend its leadership beyond its own health system, by investing in the evidence, innovations and partnerships needed to make medicines more resilient to a changing climate. Cop31 is the moment to build on that legacy – ensuring quality medicines are tough enough to withstand the climate challenges facing people everywhere..Thermodynamics does not negotiate. The women most at risk may be far from the negotiating rooms in Antalya, but the decisions made today will reach them all the same: in the heat of a labour ward, and in whether the medicine on the shelf still works.Dr Vincent Bretin is Director of Climate at Unitaid, a global health partnership hosted by the World Health Organisation. He holds a PhD in quantum physicsThis article has been produced as part of The Independent’s Rethinking Global Aid project
The world’s medicines were made for a climate that no longer exists
Full Article
Original Source
Read the full article at Independent →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.